Your shopping cart is currently empty

SENP1-IN-4, a distinct inhibitor of the deSUMOylation protease 1 (SENP1), is designed to enhance tumor radiosensitivity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $970 | Inquiry | Inquiry |
| Description | SENP1-IN-4, a distinct inhibitor of the deSUMOylation protease 1 (SENP1), is designed to enhance tumor radiosensitivity. |
| In vitro | SENP1-IN-4 enhances the responsiveness of tumor cells to irradiation, demonstrating selective cytotoxicity towards Hela cells over a range of concentrations (0.7-20 μM) across a 72-hour exposure, with an observed IC 50 value exceeding 20 μM (Cell Cytotoxicity Assay, Cell Line: Hela, Concentration: 0.7 μM, 2.2 μM, 6.6 μM, 20 μM, Incubation Time: 72 hours, Result: IC 50 >20 μM). |
| Synonyms | SENP1-IN-4 |
| Molecular Weight | 526.806 |
| Formula | C33H54N2O3 |
| Cas No. | 2416910-64-8 |
| Smiles | [H][C@@]12CC[C@]3(C)[C@]([H])(CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C)C(=O)NCC(=O)NC)[C@@]1(C)CC[C@H](O)C2(C)C |t:9| |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.